Evaluation of Code Blue activations in Covid 19 Patients andnon-COVID-19 patients: A retrospective research review
dc.contributor.author | Delen, Leman Acun | |
dc.contributor.author | Dişli, Zeliha Korkmaz | |
dc.date.accessioned | 2024-08-04T19:53:18Z | |
dc.date.available | 2024-08-04T19:53:18Z | |
dc.date.issued | 2022 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | We aimed to contribute to increase the efficiency of the Cardiopulmonary Resusitation (CPR) interventions by comparing the code blue applications activated for patients with and without COVID 19 during the pandemic process. The code blue registration forms who were diagnosed with and without COVID-19 and underwent resuscitation, between March 15-November 30, 2020 were examined retrospectively through the hospital information processing system. Demographic data, time of code blue activation, COVID-19 status, call accuracy, initial heart rhythm, respiratory arrest, survival in the first 24 hours, 30-day survival, discharge, time to reach unit. CPR durations were recorded. 79% of patients with code blue were covid-19. İnitial asystolic rhythm was present 16.7%, VF arrest was present in 34.8% and respiratory arrest was present in 71.7% patients and 53.6% of the patients died in the first 24 hours. The average time the team reaches the unit was aproximately 3 minutes, and the mean CPR duration was apoximately 30 minute. The rate initial asystolic rhythm was found higher in COVID- patients . The rate being declared exitus was higher in COVID-19 patients. The time to reach the place of activation and the duration of CPR were found higher in COVID-19 patients. The time to reach the place was found to be delayed for about 1 minute in our study. To develop strategies for minimizing the time between wearing the protective equipment properly and the response to the blue code without delay should be our first goal for the success of resuscitation. | en_US |
dc.identifier.doi | 10.5455/medscience.2021.09.291 | |
dc.identifier.endpage | 198 | en_US |
dc.identifier.issn | 2147-0634 | |
dc.identifier.issue | 1 | en_US |
dc.identifier.startpage | 195 | en_US |
dc.identifier.trdizinid | 522753 | en_US |
dc.identifier.uri | https://doi.org/10.5455/medscience.2021.09.291 | |
dc.identifier.uri | https://search.trdizin.gov.tr/yayin/detay/522753 | |
dc.identifier.uri | https://hdl.handle.net/11616/89662 | |
dc.identifier.volume | 11 | en_US |
dc.indekslendigikaynak | TR-Dizin | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | Medicine Science | en_US |
dc.relation.publicationcategory | Makale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.title | Evaluation of Code Blue activations in Covid 19 Patients andnon-COVID-19 patients: A retrospective research review | en_US |
dc.type | Article | en_US |